Moleculin Biotech, Inc. (MBRX) bonds
MBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$6.83−0.31 (-4.34%)
Close on Nov 17, 2026Market cap $133.03MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Moleculin Biotech reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Moleculin Biotech's 10-K for the period ended Dec 31, 2025
Moleculin Biotech's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| The2023 Bank Guarantee | $200.00K |
See a number that looks wrong?